Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$2.42 - $3.65 $14,541 - $21,932
-6,009 Reduced 16.15%
31,200 $78,000
Q3 2021

Nov 08, 2021

SELL
$2.82 - $3.7 $457,683 - $600,506
-162,299 Reduced 81.35%
37,209 $119,000
Q2 2021

Aug 04, 2021

BUY
$3.5 - $5.48 $193,966 - $303,696
55,419 Added 38.46%
199,508 $711,000
Q1 2021

May 10, 2021

SELL
$3.16 - $4.89 $30,573 - $47,310
-9,675 Reduced 6.29%
144,089 $507,000
Q4 2020

Feb 08, 2021

SELL
$2.2 - $4.45 $96,734 - $195,666
-43,970 Reduced 22.24%
153,764 $488,000
Q3 2020

Nov 09, 2020

BUY
$2.62 - $4.78 $518,063 - $945,168
197,734 New
197,734 $796,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $189M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.